Literature DB >> 2990544

Differential effects of oxidizing agents on human plasma alpha 1-proteinase inhibitor and human neutrophil myeloperoxidase.

N R Matheson, J Travis.   

Abstract

Human alpha 1-proteinase inhibitor is easily susceptible to inactivation because of the presence of a methionyl residue at its reactive site. Thus, oxidizing species derived from the myeloperoxidase system (enzyme, H2O2, and C1-), as well as hypochlorous acid, can inactivate this inhibitor, although H2O2 alone has no effect. Butylated hydroxytoluene, a radical scavenger, partially protects alpha 1-proteinase inhibitor from the myeloperoxidase system and completely protects it from hypochlorous acid. Each oxidant also reacts differently with the inhibitor, in that the myeloperoxidase system and hypochlorous acid can each oxidize as many as six methionyl residues, but hypochlorous acid can also oxidize a single tyrosine residue. Myeloperoxidase can be inactivated by hypochlorous acid, by autoxidation in the presence of H2O2 and C1-, as well as by H2O2 alone. Butylated hydroxytoluene completely protects this enzyme from hypochlorous acid inactivation, does not affect the action of H2O2, and enhances autoinactivation. As many as six methionyl residues and two tyrosine residues could be oxidized during autoxidation and six methionine residues by H2O2 alone. Eight methionine residues and one tyrosine residue could be oxidized by hypochlorous acid. The tyrosine residue in myeloperoxidase was oxidized only at a relatively high concentration (600 microM) of hypochlorous acid at which point the enzyme simultaneously and completely lost its enzymatic activity. Loss of activity of myeloperoxidase could also be correlated with the loss of the heme groups present in the enzyme when a relatively high concentration of hypochlorous acid (600 microM) was used and also during autoxidation. It appears that once there is sufficient oxidant to modify one of the tyrosine residues, the heme group itself becomes susceptible.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990544     DOI: 10.1021/bi00329a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  The antioxidant action of human extracellular fluids. Effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide.

Authors:  M Wasil; B Halliwell; D C Hutchison; H Baum
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

2.  Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation.

Authors:  C L Hawkins; M J Davies
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation.

Authors:  C L Hawkins; M J Davies
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

4.  Inactivation of alpha 1-proteinase inhibitor by Cu(II) and hydrogen peroxide.

Authors:  N S Kwon; P C Chan; L Kesner
Journal:  Agents Actions       Date:  1990-03

5.  Z α1-antitrypsin confers a proinflammatory phenotype that contributes to chronic obstructive pulmonary disease.

Authors:  Samuel Alam; Zhenjun Li; Carl Atkinson; Danny Jonigk; Sabina Janciauskiene; Ravi Mahadeva
Journal:  Am J Respir Crit Care Med       Date:  2014-04-15       Impact factor: 21.405

6.  Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants.

Authors:  H Fliss
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

7.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

8.  Intricacies of redoxome function demonstrated with a simple in vitro chemiluminescence method, with special reference to vitamin B12 as antioxidant.

Authors:  A Bøyum; R J Forstrøm; I Sefland; K L Sand; H B Benestad
Journal:  Scand J Immunol       Date:  2014-12       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.